Cancer is the most favoured area for pharmaceutical research and development. Although no precise figures are available, industry sources suggest that pharmaceutical and biotechnology companies worldwide spend between $3bn and $4bn a year on cancer R&D (and governments and charities spend a similar amount, led by the US National Cancer Institute).

ANGIOGENESIS
Scientists target blood supply to tumours

VIEWPOINT
George Post

NET RESOURCES
Cancer links